Cargando…
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy
Autores principales: | Montopoli, M., Zorzi, M., Cocetta, V., Prayer-Galetti, T., Guzzinati, S., Bovo, E., Rugge, M., Calcinotto, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845554/ https://www.ncbi.nlm.nih.gov/pubmed/33524477 http://dx.doi.org/10.1016/j.annonc.2021.01.069 |
Ejemplares similares
-
SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study
por: Zorzi, Manuel, et al.
Publicado: (2021) -
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)
por: Montopoli, M., et al.
Publicado: (2020) -
Genetic and hormonal influence on SARS-CoV-2-infection susceptibility: Re: The potential influence of human Y-chromosome haplogroup on COVID-19 prevalence and mortality
por: Montopoli, M., et al.
Publicado: (2020) -
Reply to the Letter to the Editor “Androgen deprivation therapy may constitute a more effective prophylactic than therapeutic strategy in COVID-19 patients” by N. Bennani and I. M. Bennani-Baiti
por: Zumerle, S., et al.
Publicado: (2020) -
Metabolic Plasticity in Chemotherapy Resistance
por: Desbats, Maria Andrea, et al.
Publicado: (2020)